The maintained progression through treatment completion is an essential time to prevent abandonment of therapy.
The reason why only a few of the control patients maintained progression during the course of the trial might be that, according to the protocol, the progression required for inclusion did not have to be proven by keratometry.
Patients who maintained progression-free intervals longer than 24 months had a 5-year survival rate of about 90%.
Patients who maintained progression-free intervals longer than 2 years had a 5-year survival rate of approximately 90%, and the rate did not increase thereafter.
The author found, between 15.8 and 42.2 % of patients experienced sustained progression based on the definitions using EDSS as the outcome, but nearly 50%% of these patients failed to maintain sustained progression for the duration of follow-up.
Having demonstrated that the STAT1-/ ERα+ mammary tumor cells required ovarian hormones for establishment of tumor growth, we next examined whether these tumors also depended on ovarian hormones to maintain tumor progression.
In their study, they suggest that VEGF-A and VEGF-B may be responsible for the initiation of tumour whereas VEGF-A and VEGF-C are further expressed in order to maintain disease progression.
In addition, 79% of patients treated with abatacept with no progression at year 1 maintained no progression of structural damage at year 2, demonstrating a durable effect on radiographic outcomes with abatacept therapy.
We wanted to maintain the progressions and general spirit of the original, so we could then twist it up with some next aesthetic, something hype".
The efficacy of treatments was evaluated in all patients who were allocated to induction treatment; response rate was recorded and follow-up for progression free survival (PFS) and overall survival (OS) was maintained till progression and death for all patients who completed the induction and concurrent treatment.
